The following is a summary of the LifeVantage Corporation (LFVN) Q4 2024 Earnings Call Transcript:

Financial Performance:

• LifeVantage reported Q4 revenue of $48.9 million, a decrease of 9.8% year-over-year.

• Adjusted EBITDA was flat compared to last year in Q4 and totaled $4.8 million, showing consistent operational profitability even amid declining revenue.

• Adjusted non-GAAP net income was $1.8 million, or $0.14 per fully diluted share, versus $2.2 million or $0.17 per share a year ago.

• Total active accounts decreased by 7.8% impacting revenue, yet revenue per account saw an increase due to changes in product mix and strong sales of TrueScience Liquid Collagen.

Business Progress:

• Introduced a new GLP-1 based weight management system, set to launch in October, aimed at naturally activating hormone production for weight management.

• Refreshed loyalty programs to increase consultant and consumer engagement and retention, integrating with LifeVantage's broader LV360 initiative.

• Continued focus on shareholder value via $1.8 million in stock repurchases and issuing a quarterly dividend of $0.04 per share, alongside strong balance sheet maintenance.

Opportunities:

• Anticipating growth from the new GLP-1 weight management product which differentiates by being 100% natural and designed for long-term use.

Risks:

• Declining total active accounts put pressure on revenue growth, indicating potential market share challenges and operational risks. Currency fluctuations also pose a financial risk affecting international market sales.

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.